January 14, 2022 -- Seegene recently unveiled three new strategies in an attempt to plan for "back-to-normal" global conditions against the COVID-19 pandemic. The company presented the plans at this week's 40th annual J.P. Morgan Healthcare virtual conference.
Seegene's three-pronged strategy includes the following:
Seegene offers the Allplex RV Master Assay, which the company says can differentiate 10 targets at the same time, including COVID-19, flu, and common respiratory viruses.
The MDx platform uses artificial intelligence and allows platform users, regardless of knowledge and experience in MDx, to develop real-time polymerase chain reaction (PCR) assays.
When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.Yes, Keep Me Current